Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prolonged higher dose methylprednisoloneversusconventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
Francesco Salton, Paola Confalonieri, Stefano Centanni, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 4, pp. 2201514-2201514
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Claudio Tirelli, Mara De Amici, Cristina Albrici, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 177-177
Open Access | Times Cited: 29
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 8
Corticosteroids in COVID-19: pros and cons
Aymen Bahsoun, Yeva Fakih, Rana Zareef, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Safety of steroids in severe community-acquired pneumonia
Federica Piedepalumbo, Ana Motos, Francesco Blasi, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240131-240131
Open Access
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, et al.
EClinicalMedicine (2025) Vol. 81, pp. 103080-103080
Closed Access
Pharmacologic Treatment and Management of Coronavirus Disease 2019
Amy Hirsch Shumaker, Adarsh Bhimraj
Infectious Disease Clinics of North America (2025)
Closed Access
Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis
Xin Ya See, Tsu Hsien Wang, Yu-Cheng Chang, et al.
BMJ Open Respiratory Research (2024) Vol. 11, Iss. 1, pp. e002141-e002141
Open Access | Times Cited: 4
Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?
Andrea S. Melani, Sara Croce, Lucia Cassai, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 329-344
Open Access | Times Cited: 11
Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs
Xiangrong Ye, Li Ye, Feng Luo, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Severe COVID-19 infection: An institutional review and literature overview
Ogheneyoma Akpoviroro, Nathan Kyle Sauers, Queeneth Uwandu, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0304960-e0304960
Open Access | Times Cited: 2
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
Francesco Salton, Paola Confalonieri, G. Umberto Meduri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 924-924
Open Access | Times Cited: 5
Effects of pharmacotherapy on post-COVID-19 pulmonary fibrosis: Systemic review
О. И. Бутранова, Elena A. Baybulatova, S. К. Zyryanov, et al.
BIO Web of Conferences (2024) Vol. 100, pp. 01010-01010
Open Access | Times Cited: 1
Intravenous high-dose anakinra drops venous thrombosis and acute coronary syndrome in severe and critical COVID-19 patients: a propensity score matched study
Ramazan Çakmak, Servet Yüce, Mustafa Ay, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Radiological lung sequelae, functional status and symptoms in older patients 3 and 6 months after hospitalization for COVID-19 pneumonia
Chiara Di Pentima, S Cecchini, Francesco Spannella, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 1075-1085
Open Access | Times Cited: 4
Real‐world effectiveness of Azvudine versus nirmatrelvir‐ritonavir in hospitalized patients with COVID‐19
Guangting Zeng, Linlin Wang, Jianqiang Li, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 4
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet
Mattia Nigro, James D. Chalmers, Stefano Aliberti
European Respiratory Journal (2023) Vol. 61, Iss. 4, pp. 2300270-2300270
Open Access | Times Cited: 3
Host-Based Treatments for Severe COVID-19
Lucrezia Mondini, Francesco Salton, Liliana Trotta, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3102-3121
Open Access | Times Cited: 3
Dexamethasone doses in patients with COVID‐19 and hypoxia: A systematic review and meta‐analysis
Marie Warrer Munch, Anders Granholm, Jan Maláska, et al.
Acta Anaesthesiologica Scandinavica (2023) Vol. 68, Iss. 2, pp. 146-166
Open Access | Times Cited: 3
High-flow nasal cannula therapy in patients with COVID-19 in intensive care units in a country with limited resources: a single-center experience
Anh-Minh Vu Phan, H. Hoang, Thanh-Son Truong, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 8
Open Access | Times Cited: 2
COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
Serap Şimşek Yavuz
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 3, pp. 165-187
Open Access | Times Cited: 2
Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Jonathan Emberson, Buddha Basnyat, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Methylprednisolone or dexamethasone? How should we choose to respond to COVID-19?: A systematic review and meta-analysis of randomized controlled trials
Zhengning Li, Yuan Xue, Laodong Li, et al.
Medicine (2023) Vol. 102, Iss. 36, pp. e34738-e34738
Open Access | Times Cited: 2
Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome
Peđja Kovačević, Jovana Malić, Tijana Kovačević, et al.
Cureus (2024)
Open Access
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study
Francesco Salton, Marco Biolo, Liliana Trotta, et al.
Medicine (2024) Vol. 103, Iss. 29, pp. e38493-e38493
Open Access
Evaluating the Risk–Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review
Daniel Hsiang-Te Tsai, Emma Harmon, Jan Goelen, et al.
Pharmacy (2024) Vol. 12, Iss. 4, pp. 129-129
Open Access
Page 1 - Next Page

Scroll to top